HireQuest (HQI) said Monday it's "disappointed" with the TrueBlue (TBI) board's rejection of its proposal to buy TrueBlue for $7.50 per share.
The company said it has filed a merger presentation with the US Securities and Exchange Commission and is encouraging TrueBlue's shareholders to review it.
HireQuest Chief Executive Rick Hermanns said the company is open to potentially increasing its offer and adding a material cash component, although it believes that it's $7.50 per share offer represents a "compelling" premium and is fair.
TrueBlue said Wednesday it adopted a limited-duration shareholder rights plan, or "poison pill," to protect investor interests in response to HireQuest's takeover offer. TrueBlue said the plan, which expires May 13, 2026, would prevent any group from gaining control without paying a fair premium or providing the board with enough time to act.
TrueBlue didn't immediately respond to a request for comment by MT Newswires on Monday.
Shares of HireQuest were down 1.7% in early trading Monday, while TrueBlue stock is up 1.3%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。